Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:STML

Stemline Therapeutics (STML) Stock Price, News & Analysis

Stemline Therapeutics logo

About Stemline Therapeutics Stock (NASDAQ:STML)

Advanced Chart

Key Stats

Today's Range
$11.83
$11.83
50-Day Range
$11.83
$11.83
52-Week Range
$3.21
$18.22
Volume
1,084 shs
Average Volume
1.52 million shs
Market Capitalization
$621.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive STML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stemline Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

STML Stock News Headlines

Trade These 7 Stocks Under $10 for Huge Profits
This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
See More Headlines

STML Stock Analysis - Frequently Asked Questions

Stemline Therapeutics Inc (NASDAQ:STML) posted its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.34) earnings per share for the quarter, beating analysts' consensus estimates of ($0.42) by $0.08. The biopharmaceutical company had revenue of $13.33 million for the quarter, compared to analysts' expectations of $13.40 million. Stemline Therapeutics had a negative trailing twelve-month return on equity of 48.14% and a negative net margin of 150.30%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stemline Therapeutics investors own include TG Therapeutics (TGTX), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Exelixis (EXEL), Sorrento Therapeutics (SRNE) and ZIOPHARM Oncology (ZIOP).

Company Calendar

Last Earnings
11/07/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:STML
CIK
1264587
Fax
N/A
Employees
92
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$76.82 million
Net Margins
-150.30%
Pretax Margin
N/A
Return on Equity
-48.14%
Return on Assets
-41.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.43
Quick Ratio
7.37

Sales & Book Value

Annual Sales
$43.22 million
Price / Sales
14.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.26 per share
Price / Book
3.63

Miscellaneous

Outstanding Shares
52,511,000
Free Float
N/A
Market Cap
$621.21 million
Optionable
Optionable
Beta
1.78
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:STML) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners